This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Third Opinion: Discussing the topline data from the phase 3 MONeT clinical trial of Pfizer's RSV vaccine ABRYSVO in patients who are immunocompromised

Ticker(s): PFE

Who's the expert?

Institution: Private Practice

  • Internal Medicine specialist in private practice.
  • Vaccinates over 1000 patients per year against Covid-19 and Influenza.

Interview Goal
to discuss the current vaccination landscape and the potential of Pfizer's ABRYSVO in patients who are immunocompromised.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.